Bile acid sequestrant

Revision as of 16:22, 27 September 2011 by Matt Pijoan (talk | contribs) (Protected "Bile acid sequestrant": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for Bile acid sequestrant

Articles

Most recent articles on Bile acid sequestrant

Most cited articles on Bile acid sequestrant

Review articles on Bile acid sequestrant

Articles on Bile acid sequestrant in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bile acid sequestrant

Images of Bile acid sequestrant

Photos of Bile acid sequestrant

Podcasts & MP3s on Bile acid sequestrant

Videos on Bile acid sequestrant

Evidence Based Medicine

Cochrane Collaboration on Bile acid sequestrant

Bandolier on Bile acid sequestrant

TRIP on Bile acid sequestrant

Clinical Trials

Ongoing Trials on Bile acid sequestrant at Clinical Trials.gov

Trial results on Bile acid sequestrant

Clinical Trials on Bile acid sequestrant at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bile acid sequestrant

NICE Guidance on Bile acid sequestrant

NHS PRODIGY Guidance

FDA on Bile acid sequestrant

CDC on Bile acid sequestrant

Books

Books on Bile acid sequestrant

News

Bile acid sequestrant in the news

Be alerted to news on Bile acid sequestrant

News trends on Bile acid sequestrant

Commentary

Blogs on Bile acid sequestrant

Definitions

Definitions of Bile acid sequestrant

Patient Resources / Community

Patient resources on Bile acid sequestrant

Discussion groups on Bile acid sequestrant

Patient Handouts on Bile acid sequestrant

Directions to Hospitals Treating Bile acid sequestrant

Risk calculators and risk factors for Bile acid sequestrant

Healthcare Provider Resources

Symptoms of Bile acid sequestrant

Causes & Risk Factors for Bile acid sequestrant

Diagnostic studies for Bile acid sequestrant

Treatment of Bile acid sequestrant

Continuing Medical Education (CME)

CME Programs on Bile acid sequestrant

International

Bile acid sequestrant en Espanol

Bile acid sequestrant en Francais

Business

Bile acid sequestrant in the Marketplace

Patents on Bile acid sequestrant

Experimental / Informatics

List of terms related to Bile acid sequestrant

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

The bile acid sequestrants are a group of medications used for binding certain components of bile in the gastrointestinal tract. They disrupt the enterohepatic circulation of bile acids by sequestering them and preventing their reabsorption from the gut. They are generally classified as hypolipidemic agents, although they may be used for purposes other than lowering cholesterol.

Mechanism of action

Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Bile acid sequestrants exchange anions such as chloride ions for bile acids. By doing so, they bind bile acids and sequester them from enterohepatic circulation.

Since bile acid sequestrants are large polymeric structures, they are not well-absorbed from the gut into the bloodstream. Thus, bile acid sequestrants, along with any bile acids bound to the drug, are excreted via the feces after passage through the gastrointestinal tract.[1]

Indications

Since bile acids are biosynthesized from cholesterol, the disruption of bile acid reabsorption will decrease cholesterol levels, particularly low density lipoprotein (commonly known as "bad cholesterol"). Therefore, they may be used for the treatment of hypercholesterolemia and dyslipidemia.

In chronic liver diseases such as cirrhosis, bile acids may deposit in the skin, causing pruritus (itching). Hence, bile acid sequenstrants may be used for the prevention of pruritus in patients with chronic liver disease.

Additionally, diarrhea may be caused by excess bile salts entering the colon rather than being absorbed at the end of the small intestine, typically shortly after eating. Bile salt diarrhea is a possible side-effect of gallbladder removal. Bile acid sequestrants may reduce diarrhea in these patients.

Examples of bile acid sequestrants

Three drugs are members of this class; all are synthetic polymeric resins:

Side effects

Since bile acid sequestrants are designed to stay in the gut, they generally do not have systemic side effects. However, they may cause problems in the gastrointestinal tract (GI tract), such as constipation, diarrhea, and flatulence. Some patients complain of the bad taste.

Drug interactions

In addition to bile acids, bile acid sequestrants may also bind drugs in the GI tract, preventing their absorption into the bloodstream. For this reason, it is generally advised that bile acid sequestrants be spaced several hours apart from other drugs.

They may also bind fat-soluble vitamins, such as vitamin A, vitamin D, vitamin E, and vitamin K. This effect may result in a vitamin deficiency. Hence, vitamin supplementation may be warranted.

Role in clinical use

Use of these agents as hypolipidemic agents has decreased markedly since the introduction of the statins, which are more efficacious than bile acid sequestrants at lowering LDL. They are occasionally used as an adjunct to the statins; this is because the fibrates (another major group of cholesterol-lowering drugs) are thought to increase the risk of rhabdomyolysis when used with statins, and so this otherwise expectable combination is frequently avoided.

Additionally, because bile acid sequestrants are not well-absorbed from the gut, they are generally regarded as being safe in pregnant women. However, by interfering with vitamin absorption, they may cause vitamin deficiencies that may affect the fetus. Hence, vitamin supplementation may be warranted, with appropriate intervals between dosing of the vitamins and bile acid sequestrants.

References

  1. FDA Heart Health Online - Bile Acid Sequestrants
  2. Wong NN (2001). "Colesevelam: a new bile acid sequestrant". Heart disease (Hagerstown, Md.). 3 (1): 63–70. PMID 11975771.

Template:Lipid modifying agents Template:SIB th:ไบล์แอซิดซีเควสแตนต์


Template:WikiDoc Sources